1. Home
  2. NEXA vs PVLA Comparison

NEXA vs PVLA Comparison

Compare NEXA & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexa Resources S.A.

NEXA

Nexa Resources S.A.

HOLD

Current Price

$11.92

Market Cap

1.0B

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$82.17

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXA
PVLA
Founded
1956
2015
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
NEXA
PVLA
Price
$11.92
$82.17
Analyst Decision
Hold
Strong Buy
Analyst Count
5
17
Target Price
$7.70
$145.24
AVG Volume (30 Days)
750.4K
277.5K
Earning Date
02-26-2026
03-30-2026
Dividend Yield
0.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,839,970,000.00
N/A
Revenue This Year
$5.98
N/A
Revenue Next Year
$6.99
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.95
N/A
52 Week Low
$4.44
$16.65
52 Week High
$14.94
$114.69

Technical Indicators

Market Signals
Indicator
NEXA
PVLA
Relative Strength Index (RSI) 49.23 47.33
Support Level $11.76 $76.50
Resistance Level $13.05 $84.69
Average True Range (ATR) 0.88 6.16
MACD -0.34 0.38
Stochastic Oscillator 18.02 72.22

Price Performance

Historical Comparison
NEXA
PVLA

About NEXA Nexa Resources S.A.

Nexa Resources SA is a low-cost integrated zinc producer. It produces copper, silver, and gold as byproducts. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Share on Social Networks: